My Quote Request
6505-01-026-0166
20 Products
TRIAVIL 4-25 TABLETS
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505010260166
NSN
6505-01-026-0166
TRIAVIL 4-25 TABLETS
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505010260166
NSN
6505-01-026-0166
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS PERPHENAZINE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: ENTERIC COATED
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
CATAPRES TABLETS
CLONIDINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010249879
NSN
6505-01-024-9879
CATAPRES TABLETS
CLONIDINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010249879
NSN
6505-01-024-9879
MFG
BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS CLONIDINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLONIDINE HYDROCHLORIDE TABLETS 0.2MG 1000S
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: USE PREFERRED JDF NSN 6505010058425
Related Searches:
NDC00005-3181-34
CLONIDINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010249879
NSN
6505-01-024-9879
NDC00005-3181-34
CLONIDINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010249879
NSN
6505-01-024-9879
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS CLONIDINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLONIDINE HYDROCHLORIDE TABLETS 0.2MG 1000S
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: USE PREFERRED JDF NSN 6505010058425
Related Searches:
NDC00378-0186-10
CLONIDINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010249879
NSN
6505-01-024-9879
NDC00378-0186-10
CLONIDINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010249879
NSN
6505-01-024-9879
MFG
CARDINAL HEALTH 100 INC DBA BINDLEY WESTERN TENNESSEE DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS CLONIDINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLONIDINE HYDROCHLORIDE TABLETS 0.2MG 1000S
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: USE PREFERRED JDF NSN 6505010058425
Related Searches:
NDC00597-0007-10
CLONIDINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010249879
NSN
6505-01-024-9879
NDC00597-0007-10
CLONIDINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010249879
NSN
6505-01-024-9879
MFG
BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS CLONIDINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLONIDINE HYDROCHLORIDE TABLETS 0.2MG 1000S
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: USE PREFERRED JDF NSN 6505010058425
Related Searches:
NDC00781-1472-10
CLONIDINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010249879
NSN
6505-01-024-9879
NDC00781-1472-10
CLONIDINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010249879
NSN
6505-01-024-9879
MFG
SANDOZ INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS CLONIDINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLONIDINE HYDROCHLORIDE TABLETS 0.2MG 1000S
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: USE PREFERRED JDF NSN 6505010058425
Related Searches:
NDC54-8712-00
POTASSIUM CHLORIDE ORAL SOLUTION,USP
NSN, MFG P/N
6505010254637
NSN
6505-01-025-4637
NDC54-8712-00
POTASSIUM CHLORIDE ORAL SOLUTION,USP
NSN, MFG P/N
6505010254637
NSN
6505-01-025-4637
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V POTASSIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 22.500 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
75525
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505010258575
NSN
6505-01-025-8575
75525
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505010258575
NSN
6505-01-025-8575
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 90.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00140-0007-52
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505010258575
NSN
6505-01-025-8575
NDC00140-0007-52
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505010258575
NSN
6505-01-025-8575
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 90.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00879-0501-09
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505010258575
NSN
6505-01-025-8575
NDC00879-0501-09
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505010258575
NSN
6505-01-025-8575
MFG
HALSEY DRUG CO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 90.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00140-0007-51
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505010258576
NSN
6505-01-025-8576
NDC00140-0007-51
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505010258576
NSN
6505-01-025-8576
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 120.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ACTIVE MEDICAMENT MEDICINAL STRENGTH:5.000 MILLIGRAMS OF CHLORDIAZEPOXIDE ACTIVE INGREDIENTS
Related Searches:
NDC00879-0501-23
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505010258576
NSN
6505-01-025-8576
NDC00879-0501-23
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505010258576
NSN
6505-01-025-8576
MFG
HALSEY DRUG CO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 120.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ACTIVE MEDICAMENT MEDICINAL STRENGTH:5.000 MILLIGRAMS OF CHLORDIAZEPOXIDE ACTIVE INGREDIENTS
Related Searches:
76822
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010258582
NSN
6505-01-025-8582
76822
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010258582
NSN
6505-01-025-8582
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 90.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
LIBRIUM
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010258582
NSN
6505-01-025-8582
LIBRIUM
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010258582
NSN
6505-01-025-8582
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 90.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00140-0003-52
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010258582
NSN
6505-01-025-8582
NDC00140-0003-52
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010258582
NSN
6505-01-025-8582
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 90.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00777-0503-24
TOBRAMYCIN INJECTION,USP
NSN, MFG P/N
6505010258647
NSN
6505-01-025-8647
NDC00777-0503-24
TOBRAMYCIN INJECTION,USP
NSN, MFG P/N
6505010258647
NSN
6505-01-025-8647
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40 MG TOBRAMYCIN SULFATE PER ML
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: 23 GAGE NEEDLE
Related Searches:
NEBCIN
TOBRAMYCIN INJECTION,USP
NSN, MFG P/N
6505010258647
NSN
6505-01-025-8647
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40 MG TOBRAMYCIN SULFATE PER ML
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: 23 GAGE NEEDLE
Related Searches:
NDC52544-0815-34
LOXAPINE HYDROCHLORIDE ORAL SOLUTION
NSN, MFG P/N
6505010260101
NSN
6505-01-026-0101
NDC52544-0815-34
LOXAPINE HYDROCHLORIDE ORAL SOLUTION
NSN, MFG P/N
6505010260101
NSN
6505-01-026-0101
MFG
WATSON LABS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS LOXAPINE EQUIVALENT PER MILLILITER
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES OR 120.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONCENTRATED; WITH CALIBRATED DROPPER
Related Searches:
3312
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505010260166
NSN
6505-01-026-0166
3312
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505010260166
NSN
6505-01-026-0166
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS PERPHENAZINE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: ENTERIC COATED
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00006-0946-74
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505010260166
NSN
6505-01-026-0166
NDC00006-0946-74
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505010260166
NSN
6505-01-026-0166
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS PERPHENAZINE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: ENTERIC COATED
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1